Heyll A - Search Results

1

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study.

Fenk R, Schneider P, Kropff M, Huenerlituerkoglu AN, Steidl U, Aul C, Hildebrandt B, Haas R, Heyll A, Kobbe G; West German Myeloma Study Group. Fenk R, et al. Among authors: heyll a. Br J Haematol. 2005 Aug;130(4):588-94. doi: 10.1111/j.1365-2141.2005.05641.x. Br J Haematol. 2005. PMID: 16098074 Free article. Clinical Trial.

2

Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.

Kobbe G, Schneider P, Aivado M, Zohren F, Schubert D, Fenk R, Neumann F, Kronenwett R, Pape H, Rong A, Royer-Pokora B, Hildebrandt B, Germing U, Gattermann N, Heyll A, Haas R. Kobbe G, et al. Among authors: heyll a. Exp Hematol. 2002 Nov;30(11):1346-53. doi: 10.1016/s0301-472x(02)00923-2. Exp Hematol. 2002. PMID: 12423689 Free article.

3

Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients.

Heyll A, Söhngen D, Kobbe G, Schneider P, Bauser U, Thiele KP, Wehmeier A, Südhoff T, Quenzel EM, Rieth C, Wernet P, Fischer J, Frick M, Aul C. Heyll A, et al. Leukemia. 1997 Dec;11 Suppl 5:S32-4. Leukemia. 1997. PMID: 9436936 Clinical Trial.

4

[High-dose chemotherapy of patients with multiple myeloma].

Heyll A, Söhngen D, Aul C, Schneider P, Kobbe G, Bauser U, Quenzel EM, Schneider W. Heyll A, et al. Praxis (Bern 1994). 1998 Jun 24;87(25-26):879-83. Praxis (Bern 1994). 1998. PMID: 9702091 German.

5

Massive extramedullary disease progression in a patient with stable multiple myeloma during G-CSF priming for peripheral blood progenitor mobilization.

Kobbe G, Germing U, Soehngen D, Aul C, Heyll A. Kobbe G, et al. Among authors: heyll a. Oncol Rep. 1999 Sep-Oct;6(5):1151-2. doi: 10.3892/or.6.5.1151. Oncol Rep. 1999. PMID: 10425318

6

Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support.

Strupp C, Sudhoff T, Germing U, Hunerliturkoglu A, Schneider P, Niederste-Hollenberg A, Heyll A, Aul C. Strupp C, et al. Among authors: heyll a. Oncol Rep. 2000 May-Jun;7(3):659-61. doi: 10.3892/or.7.3.659. Oncol Rep. 2000. PMID: 10767386

7

[Indications for chemotherapy in multiple myeloma].

Heyll A, Aul C. Heyll A, et al. Dtsch Med Wochenschr. 1996 May 17;121(20):675. Dtsch Med Wochenschr. 1996. PMID: 8635404 German. No abstract available.

8

Long-term survival of recipients of allogeneic bone-marrow transplantation after mechanical ventilation.

Hollmig KA, Soehngen D, Leschke M, Kobbe G, Schneider P, Klein RM, Aul C, Heyll A. Hollmig KA, et al. Among authors: heyll a. Eur J Med Res. 1997 Feb 21;2(2):62-6. Eur J Med Res. 1997. PMID: 9085016

9

Early occurrence of an adenocarcinoma after allogeneic bone marrow transplantation in a patient with AML.

Germing U, Kobbe G, Sohngen D, Motherby H, Braunstein S, Heyll A, Aul C. Germing U, et al. Among authors: heyll a. Oncol Rep. 1999 Jul-Aug;6(4):855-7. doi: 10.3892/or.6.4.855. Oncol Rep. 1999. PMID: 10373670

10

Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma.

Kobbe G, Söhngen D, Bauser U, Schneider P, Germing U, Thiele KP, Rieth C, Hünerlitürkoglu A, Fischer J, Frick M, Wernet P, Aul C, Heyll A. Kobbe G, et al. Among authors: heyll a. Ann Hematol. 1999 Oct;78(10):456-62. doi: 10.1007/s002770050598. Ann Hematol. 1999. PMID: 10550556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters